For: | Wang QW, Zhang XT, Lu M, Shen L. Impact of duration of adjuvant chemotherapy in radically resected patients with T4bN1-3M0/TxN3bM0 gastric cancer. World J Gastrointest Oncol 2018; 10(1): 31-39 [PMID: 29375746 DOI: 10.4251/wjgo.v10.i1.31] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v10/i1/31.htm |
Number | Citing Articles |
1 |
Cheng Chen, Cheng Wu Tang, San Xiong Huang, Chun Lei Shen. Efficacy and Safety of Additional S-1 Chemotherapy to S-1 Plus Oxaliplatin Regimen Chemotherapy for Stage III Gastric Carcinoma after Radical Resection. Cancer Investigation 2022; 40(1): 73 doi: 10.1080/07357907.2021.1988961
|
2 |
Wei Yang, Bian Wu, Ning Ma, Yongfang Wang, Jianhui Guo, Jun Zhu, Sihui Zhao. BATF2 reverses multidrug resistance of human gastric cancer cells by suppressing Wnt/β-catenin signaling. In Vitro Cellular & Developmental Biology - Animal 2019; 55(6): 445 doi: 10.1007/s11626-019-00360-5
|
3 |
Xinmiao Wang, Heping Wang, Luchang Cao, Jingyuan Wu, Taicheng Lu, Shixin Li, Jie Li. Efficacy and Safety of Brucea javanica Oil Emulsion Injection in the Treatment of Gastric Cancer: A Systematic Review and Meta-Analysis. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.784164
|
4 |
Lei Chen, Chenghai Zhang, Zhendan Yao, Ming Cui, Jiadi Xing, Hong Yang, Nan Zhang, Maoxing Liu, Kai Xu, Fei Tan, Yuzhe Li, Beihai Jiang, Xiangqian Su. Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08717-4
|
5 |
A. A. Bobryshev, M. M. Davudov, M. N. Narimanov, S. B. Polycarpova, V. Y. Kirsanov, V. N. Blindar. THE ROLE OF ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF LOCALLY ADVANCED GASTRIC CANCER. Siberian journal of oncology 2021; 20(1): 133 doi: 10.21294/1814-4861-2021-20-1-133-140
|
6 |
Xianmei Lv, Qiusheng Guo, Liming Xu, Dongyu Li. Study on the Chemotherapeutic Effect and Mechanism of Doxorubicin Hydrochloride on Drug-Resistant Gastric Cancer Cell Lines Using Metal-Organic Framework Fluorescent Nanoparticles as Carriers. Journal of Nanomaterials 2020; 2020: 1 doi: 10.1155/2020/6681749
|
7 |
Bibo Tan, Yong Li, Qun Zhao, Liqiao Fan, Dong Wang. ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting miR-185
. Bioscience Reports 2018; 38(5) doi: 10.1042/BSR20181023
|
8 |
Chengwu Tang, Wenming Feng, Ying Bao, Cheng Chen. <p>Maintenance Chemotherapy with S-1 Following SOX Regimen Chemotherapy Improves Prognosis of Stage 3 Gastric Cancer After D2 Gastrectomy: A 5-Year Analysis</p>. OncoTargets and Therapy 2020; : 12661 doi: 10.2147/OTT.S271884
|